 |
Previous Article | Next Article 
The Journal of Neuroscience, February 15, 2001, 21(4):1110-1116
Schwann Cell Proliferative Responses to cAMP and
Nf1 Are Mediated by Cyclin D1
Haesun A.
Kim1,
Nancy
Ratner3,
Thomas M.
Roberts2, and
Charles D.
Stiles1
Departments of 1 Microbiology and Molecular Genetics
and 2 Pathology, Harvard Medical School and the Dana-Farber
Cancer Institute, Boston, Massachusetts 02115, and
3 Department of Cell Biology, Neurobiology and Anatomy,
College of Medicine, University of Cincinnati, Cincinnati, Ohio 45267
In most mammalian cells, the cAMP-dependent protein kinase A
pathway promotes growth arrest and cell differentiation. However in
Schwann cells, the reverse is true. Elevated levels of cAMP function as
the cofactor to a broad range of mitogenic cues in culture and in
animals. Previous studies have suggested that cAMP acts at an early
point in the Schwann cell mitogenic response, perhaps by stimulating
the expression of growth factor receptors. We show here that cAMP acts
downstream rather than upstream of growth factor receptor expression.
The essential function(s) of cAMP is exerted as Schwann cells progress
through the G1 phase of the cell cycle. Ectopic expression
studies using an inducible retroviral vector show that the
G1 phase requirement for cAMP can be alleviated by a single
protein, cyclin D1. We show, in addition, that at least one function of
the Nf1 tumor suppressor is to antagonize the
accumulation of cAMP and the expression of cyclin D1 in Schwann cells.
Thus a G1 phase-specific protein, cyclin D1, accounts for
two salient features of Schwann cell growth control: the promitotic
response to cAMP and the antimitotic response to the Nf1
tumor suppressor.
Key words:
Schwann cell; platelet-derived growth factor; cAMP; cyclin D1; cell cycle; neurofibromatosis
Copyright © 2001 Society for Neuroscience 0270-6474/01/2141110-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
L. S Kirschner, Z. Yin, G. N Jones, and E. Mahoney
Mouse models of altered protein kinase A signaling
Endocr. Relat. Cancer,
September 1, 2009;
16(3):
773 - 793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhang, X.-W. Fei, Y.-L. He, G. Yang, and Y.-A. Mei
Bradykinin inhibits the transient outward K+ current in mouse Schwann cells via the cAMP/PKA pathway
Am J Physiol Cell Physiol,
June 1, 2009;
296(6):
C1364 - C1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Warrington and J. B. Rubin
Phosphodiesterase-4 Inhibition and Brain Tumor Growth
Clin. Cancer Res.,
May 1, 2009;
15(9):
3238 - 3238.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Monje, G. Athauda, and P. M. Wood
Protein Kinase A-mediated Gating of Neuregulin-dependent ErbB2-ErbB3 Activation Underlies the Synergistic Action of cAMP on Schwann Cell Proliferation
J. Biol. Chem.,
December 5, 2008;
283(49):
34087 - 34100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Kirschner, D. F. Kusewitt, L. Matyakhina, W. H. Towns II, J. A. Carney, H. Westphal, and C. A. Stratakis
A Mouse Model for the Carney Complex Tumor Syndrome Develops Neoplasia in Cyclic AMP-Responsive Tissues
Cancer Res.,
June 1, 2005;
65(11):
4506 - 4514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Parkinson, A. Bhaskaran, A. Droggiti, S. Dickinson, M. D'Antonio, R. Mirsky, and K. R. Jessen
Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death
J. Cell Biol.,
February 2, 2004;
164(3):
385 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dasgupta, L. L. Dugan, and D. H. Gutmann
The Neurofibromatosis 1 Gene Product Neurofibromin Regulates Pituitary Adenylate Cyclase-Activating Polypeptide-Mediated Signaling in Astrocytes
J. Neurosci.,
October 1, 2003;
23(26):
8949 - 8954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xu, N. Chiamvimonvat, A. E. Vazquez, S. Akunuru, N. Ratner, and E. N. Yamoah
Gene-Targeted Deletion of Neurofibromin Enhances the Expression of a Transient Outward K+ Current in Schwann Cells: A Protein Kinase A-Mediated Mechanism
J. Neurosci.,
November 1, 2002;
22(21):
9194 - 9202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Stevens and R. D. Fields
Regulation of the Cell Cycle in Normal and Pathological Glia
Neuroscientist,
April 1, 2002;
8(2):
93 - 97.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Gutmann, Y. L. Wu, N. M. Hedrick, Y. Zhu, A. Guha, and L. F. Parada
Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes
Hum. Mol. Genet.,
December 1, 2001;
10(26):
3009 - 3016.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|